JPM
JPMorgan Chase & Co.
JPM has the edge over MCBS overall, supported by stronger modeled upside and stronger fundamentals.
MCBS
MetroCity Bankshares, Inc.
MCBS trails on the overall score without a compensating advantage in the available component scores.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
MCBS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MCBS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MCBS.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
MCBS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8x | $24.63 | -32% |
| Fair | 11x | $33.20 | -8.4% |
| Current | 12x | $36.26 | — |
| Forward | 12x | $36.26 | — |
| Expensive | 13x | $38.33 | +5.7% |
Historical ranges are pointers, not guarantees.
MCBS has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
JPM has the edge over MCBS on the outlook, with more favorable earnings and revenue expectations.
MCBS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect MCBS's earnings, revenue and profitability to hold roughly steady.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
MCBS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.13 | +2.3% |
| Q3 2026 | $3.06 | +18% |
| Q2 2026 | $2.89 | +12% |
| Q1 2026 | $2.78 | +7.8% |
| Q4 2025 | $2.64 | +4.8% |
| Q3 2025 | $2.59 | +12% |
| Q2 2025 | $2.57 | +21% |
| Q1 2025 | $2.58 | +31% |
| Q4 2024 | $2.52 | +25% |
MCBS has the edge over JPM on earnings, with stronger typical year-over-year growth.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
MCBS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $47.9M | +26% |
| Q2 2026 | $49.8M | +31% |
| Q1 2026 | $50.8M | +41% |
| Q4 2025 | $43.7M | +24% |
| Q3 2025 | $38M | +2.9% |
| Q2 2025 | $37.9M | +4.5% |
| Q1 2025 | $36M | +10% |
| Q4 2024 | $35.4M | +15% |
MCBS has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 58% | -4.4 points |
| Q2 2026 | 62% | -0.9 points |
| Q1 2026 | 59% | -1.9 points |
| Q4 2025 | 53% | -6.1 points |
| Q3 2025 | 63% | +1.4 points |
| Q2 2025 | 62% | -2 points |
| Q1 2025 | 61% | -1.3 points |
| Q4 2024 | 59% | +6.3 points |
MCBS has the edge over JPM on profitability, with a higher operating margin.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
MCBS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$16.6M | -203% |
| Q2 2026 | $24.9M | +74% |
| Q1 2026 | $45.8M | +287% |
| Q4 2025 | -$5.4M | -128% |
| Q3 2025 | $16.2M | +$28M |
| Q2 2025 | $14.3M | -25% |
| Q1 2025 | $11.8M | -67% |
| Q4 2024 | $18.9M | +$28.1M |
MCBS has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over MCBS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
MCBS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +88K shares |
| 1 year | +12% | +3.2M shares |
| 3 years | +13% | +3.4M shares |
| 5 years | +13% | +3.3M shares |
| Available history | +17% | +4.3M shares |
MCBS has 29M diluted shares, up 12% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $4.4M |
| Q4 2025 | $2.7M |
| Q3 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q4 2023 | $706,000 |
MCBS spent $7M buying back its own shares over the past year.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
MCBS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 1.0x | Healthy |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 2.1x | Moderate |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.5x | Healthy |
| Q4 2024 | 1.4x | Healthy |
MCBS's net debt is less than a year of its operating earnings (EBITDA), down from 2.1 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MCBS.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
MCBS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.8 | Neutral |
| Stochastic | 72.1 | Neutral |
MCBS's weekly RSI is 62 (neutral) and its Stochastic is 72 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
MCBS PE vs Financial Services Sector
| Metric | MCBS | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 9% below |
| PE % | 69 | 63 | 6 pts above |
MCBS has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
MCBS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $35.4 | 2.3% above |
| 20 week MA | $35.6 | 1.8% above |
| 50 week MA | $32.3 | 12% above |
| 100 week MA | $30.4 | 19% above |
| 200 week MA | $26.9 | 35% above |
MCBS has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
MCBS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.5 | $14.3 | -18% |
| 2021 | $14.3 | $27.6 | +93% |
| 2022 | $27.6 | $21.6 | -22% |
| 2023 | $21.6 | $24.0 | +11% |
| 2024 | $24.0 | $32.0 | +33% |
| 2025 | $32.0 | $26.8 | -16% |
| 2026 YTD | $26.8 | $36.3 | +35% |
MCBS has the edge over JPM on returns for 2026, with the stronger performance.